(Q33579356)

28 July 2017

title

Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis (English)

1 reference

28 July 2017

author name string

Vlachoyiannopoulos PG

1

1 reference

28 July 2017

Tsifetaki N

2

1 reference

28 July 2017

Dimitriou I

3

1 reference

28 July 2017

Galaris D

4

1 reference

28 July 2017

Papiris SA

5

1 reference

28 July 2017

Moutsopoulos HM

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

55

1 reference

28 July 2017

issue

10

1 reference

28 July 2017

page(s)

761-768

1 reference

A radical proposal for the pathogenesis of scleroderma

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Selective inhibition of human diploid fibroblast collagen synthesis by interferons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Connective tissue synthesis by scleroderma skin fibroblasts in cell culture

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Recombinant interferon-gamma in the treatment of systemic sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Microvasculature in systemic sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Treatment of systemic sclerosis with gamma-interferon

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Induction of T-cell activation by oxidized low density lipoprotein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Cellular infiltrates in scleroderma skin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Endothelial injury in scleroderma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010296

A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels

31 October 2018

1 reference

12 December 2020

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon

1 reference

12 December 2020

Chromosome breakage and sister chromatid exchange frequencies in scleroderma

1 reference

12 December 2020

Endothelial injury in scleroderma. A protease mechanism

1 reference

12 December 2020

45 Measurement of O2− production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils

1 reference

12 December 2020

Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations

1 reference

12 December 2020

Activation by gamma interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased Km of the superoxide-generating NADPH oxidase

1 reference

12 December 2020

A modified scleroderma skin scoring method

1 reference

12 December 2020

ENHANCED OXIDATIVE METABOLISM OF NEUTROPHILS FROM PATIENTS WITH SYSTEMIC SCLEROSIS

1 reference

12 December 2020

Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C

1 reference

12 December 2020

Differential effects of gamma-interferon on collagen and fibronectin gene expression

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Soluble immunologic products in scleroderma sera

1 reference

12 December 2020

Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid

1 reference

12 December 2020

Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins

1 reference

12 December 2020

Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial

1 reference

12 December 2020

Increased susceptibility to oxidation of low‐density lipoproteins isolated from patients with systemic sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.55.10.761

1 reference

28 July 2017

1 reference

28 July 2017

1 reference